The market has been high on Quidel Corporation (QDEL) stock recently. QDEL gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.
Quidel Corporation has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on QDEL!
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With QDEL Stock Today?
Quidel Corporation (QDEL) stock has risen 1.28% while the S&P 500 has fallen -0.28% as of 10:27 AM on Tuesday, Nov 30. QDEL has gained $1.92 from the previous closing price of $149.80 on volume of 92,542 shares. Over the past year the S&P 500 has gained 28.19% while QDEL has fallen -22.21%. QDEL earned $20.40 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 7.42.
More About Quidel Corporation
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.
Click Here to get the full Stock Report for Quidel Corporation stock.